Clinical trial
Feasibility of Outpatient Induction Chemotherapy for Adult Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
NCT01807091 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of Outpatient Induction Chemotherapy for Adult Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
- Lead sponsor
- University of Washington
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 21, 2013
- Completion date
- January 8, 2020
- Enrollment
- 17 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
adult acute myeloid leukemia, adult myelodysplastic syndrome